“…With the discovery of more amyloid proteins this immunohistochemical option of a relatively easy and direct way of typing amyloid was extended, resulting in a panel of antibodies that could be applied to solve various questions concerning the classifi cation of amyloidoses in patients and in retrospective lists of various tissues using several immunohistochemical variants Casanova et al, 1992;Röcken et al, 1996aRöcken et al, , 1996bArbustini et al, 1997;Strege et al, 1998;DeCarvalho et al, 2004). In particular, amyloids in biopsies of neural tissue (Feurle et al, 1984;Staunton et al, 1987;Li et al, 1992;Jenne et al, 1996), cerebral tissue (Allsop et al, 1988;Kitamoto et al, 1987;Baron et al, 1988;Schröder et al, 1995;Schröder and Linke, 1999), carpal tunnel tissue (Stein et al, 1987;Kyle et al, 1992), endomyocardial bioptic tissue (Frenzel et al, 1986), lymph node tissue (Newland et al, 1986), laryngeal tissue (Godbersen et al, 1992), skin tissue (Bieber et al, 1988;Dithmar et al, 2004), and subcutaneous tissue (Orfi la et al, 1986) have been classifi ed on formalin-fi xed paraffi n sections. The identifi cation of amyloids can also be performed using peptide antibodies (Westermark et al, 1987(Westermark et al, , 1999Solomon et al, 2003a).…”